Therapeutic targeting of acute myeloid leukemia (AML) is hampered by intra- and inter-tumoral cell state heterogeneity. To develop a more precise understanding of AML cell states, we constructed a reference atlas of human hematopoiesis from 263,159 single-cell transcriptomes spanning 55 cellular states. Using this atlas, we mapped more than 1.2 million cells spanning 318 leukemia samples, revealing 12 recurrent patterns of aberrant differentiation in AML. Notably, this uncovered unexpected AML cell states resembling lymphoid and erythroid progenitors that were prognostic within the clinically heterogeneous context of normal karyotype AML, independent of genomic classifications. Systematic mapping of genotype-to-phenotype associations revealed specific differentiation landscapes associated with more than 45 genetic drivers. Importantly, distinct cellular hierarchies can arise from samples sharing the same genetic driver, potentially reflecting distinct cellular origins for disease-sustaining leukemia stem cells. Thus, precise mapping of malignant cell states provides insights into leukemogenesis and refines disease classification in acute leukemia. Significance: We present a single-cell reference atlas of human hematopoiesis and a computational tool for rapid mapping and classification of healthy and leukemic cells. Applied to AML, this has enabled single-cell analysis at the scale of hundreds of patient samples, revealing the full breadth of derailment of differentiation in AML. See related commentary by Berger and Penter, p. 280
Supplementary Figure S18. Distinct LSC-driven leukemia cell hierarchies co-existing within AML pt.90394 A-F) Experimental workflow for identifying co-existing LSC-driven hierarchies as in Main Figure 7, applied to pt.90394. A) Immunophenotype and scRNA-seq cell state composition of the primary AML sample. B) scRNA-seq projection results of the primary AML sample. C) Immunophenotype and scRNA-seq composition for the primary CD34+CD38- sorted fraction, representing 0.17% of primary cells. D) Immunophenotype and scRNA-seq composition for the PDX sample derived from injection of the CD34+CD38- sorted fraction. E) Immunophenotype and scRNA-seq composition for the primary CD34-CD38+ sorted fraction, representing 16% of primary cells. F) Immunophenotype and scRNA-seq composition for the PDX sample derived from injection of the CD34-CD38+ sorted fraction.
Therapeutic targeting of acute myeloid leukemia (AML) is hampered by intra- and inter-tumoral cell state heterogeneity. To develop a more precise understanding of AML cell states, we constructed a reference atlas of human hematopoiesis from 263,159 single-cell transcriptomes spanning 55 cellular states. Using this atlas, we mapped more than 1.2 million cells spanning 318 leukemia samples, revealing 12 recurrent patterns of aberrant differentiation in AML. Notably, this uncovered unexpected AML cell states resembling lymphoid and erythroid progenitors that were prognostic within the clinically heterogeneous context of normal karyotype AML, independent of genomic classifications. Systematic mapping of genotype-to-phenotype associations revealed specific differentiation landscapes associated with more than 45 genetic drivers. Importantly, distinct cellular hierarchies can arise from samples sharing the same genetic driver, potentially reflecting distinct cellular origins for disease-sustaining leukemia stem cells. Thus, precise mapping of malignant cell states provides insights into leukemogenesis and refines disease classification in acute leukemia.Significance:We present a single-cell reference atlas of human hematopoiesis and a computational tool for rapid mapping and classification of healthy and leukemic cells. Applied to AML, this has enabled single-cell analysis at the scale of hundreds of patient samples, revealing the full breadth of derailment of differentiation in AML.See related commentary by Berger and Penter, p. 280
Supplementary Figure S10. Single-cell composition analysis within defined genomic subtypes of AML Single cell composition heatmaps are shown for AML patients belonging to specific genomic subtypes of AML, including: (A) KMT2A-rearranged AML (n = 33), (B) CBFB::MYH11 driven AML (n = 14), (C) RUNX1::RUNX1T1 driven AML (n = 18), (D) NPM1 mutated AML (n = 56), and (E) AML with TP53 mutations or Complex Karyotype (n = 34). The heatmap depicts the centered log ratio (CLR) normalized abundance of individual cell states within each patient sample, clipped at 0 and 4.5 for visualization. Each sample is annotated based on the study of origin, specific disease diagnosis, age group, and AML hierarchy classification. Cell state heterogeneity, quantified by the Shannon diversity index, is also shown for each sample. When present, recurrent genomic alterations are also annotated for each scRNA-seq patient sample.
Supplementary Figure S11. Inference of AML differentiation state abundance from bulk RNA-seq profiles A) Depiction of broad differentiation states in AML, each spanning multiple cell states. AML differentiation states were defined by single-cell composition analysis from Supplementary Figure S7B. Cell states which do not belong to a defined AML differentiation state (due to lack of correlation across AML samples) are shown in grey. B) Marker genes specific to each differentiation state in AML. Cells belonging to each differentiation state from each patient were pooled prior to differential expression analysis and heatmap visualization. C) LASSO regression to estimate AML differentiation state abundance in 302 pseudo-bulk samples wherein cells from individual patients were aggregated together. Marker genes for each differentiation state were used as features for LASSO regression, and cross-validation results of inferred abundances by LASSO in held-out patient subsets are depicted for each differentiation state. P values from a two-tailed Wilcoxon rank-sum test are shown. Box plots indicate the range of the central 50% of the data with the central line marking the median. Whiskers extend from each both to 1.5x the interquartile range. D) Number of positively and negatively weighted genes comprising each LASSO regression model for predicting abundance of each AML differentiation state in bulk RNA-seq data. E) Predicted and observed differentiation state abundance across 302 AML pseudo-bulk samples. For each association, the linear regression line as well as r and P values from Pearson correlation are shown.